MedTrace Logo

Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

NCT01025024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1224

Last updated 2009-12-03

No results posted yet for this study

Summary

A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.

Conditions

  • Single-nucleotide Polymorphism (SNP) for Glaucoma

Interventions

GENETIC

SNP analysis of the DNA

SNP analysis of the DNA obtained from peripheral blood sample

Sponsors & Collaborators

  • Korea Healthcare Technology R&D Project

    collaborator UNKNOWN

  • Korea Advanced Institute of Science and Technology

    collaborator OTHER

  • Chungnam National University

    lead OTHER

Principal Investigators

  • Chang-sik Kim, professor · Department of Ophthalmology, Chungnam National University Hospital

  • Changwon Kang, professor · Korea Advanced Institute of Science and Technology

  • Kyunglan Kim · Department of Biological Sciences, Korea Advanced Institute of Science and Technology

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-10-31
Completion
2009-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01025024 on ClinicalTrials.gov